Navigation Links
DART Therapeutics Develops Drug Candidate for Duchenne Muscular Dystrophy
Date:3/20/2013

of SARMs for other neuromuscular diseases such as FSHD (Facioscapulohumeral muscular dystrophy), Spinal Muscular Atrophy, Charcot Marie Tooth and ALS (Amyotrophic lateral sclerosis).

"We know that making DMD a chronic, manageable disease will require a cocktail of therapies," said Dr. Diana Escolar , Chief Medical Officer of DART Therapeutics. "Phase one studies in adult volunteers show that DT-200 is safe and well-tolerated. Through our work with this SARM, we intend to explore the value of increasing muscle mass and potentially strength in diseased muscle, which could lead to development of a therapy that addresses a key unmet need in the future DMD cocktail."

In the second half of 2013, DART will initiate a phase 2a study in adults with normal muscle followed by a study in abnormal muscle wasting to assess the effects of DT-200 in increasing lean body mass, muscle strength and motor function. This study will provide proof of concept that either normal muscle, abnormal muscle or both can respond to SARMs, and that the effect in increasing muscle mass will be clinically beneficial. Further studies in pediatric DMD or other neuromuscular disorders will follow if these studies are positive.

"DART was created in part to explore the unanswered questions in DMD," said Gene Williams , CEO of DART. "Our model gives us a unique opportunity to ask the difficult questions and commit research dollars to areas that may have been neglected due to time and cost constraints normally associated with traditional biotech firms. We are optimistic that SARMs will play a role in the eventual DMD cocktail and may yield benefits for several other rare diseases, which we hope will benefit children beyond the DMD community."

Galapagos completed a phase one study of its SARM drug candidate in healthy volunteers, which showed positive results in terms of exposure and tolerability. Several Proof of Conce
'/>"/>

SOURCE DART Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
2. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
3. Mast Therapeutics Reports Fourth Quarter And Full Year 2012 Financial Results
4. Echo Therapeutics Achieves ISO 13485 Certification
5. Orexigen Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
6. Echo Therapeutics Appoints Robert Doman to Board of Directors
7. Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect
8. ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"
9. Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference
10. PTC Therapeutics Closes $60 Million Private Financing
11. Orexigen Therapeutics to Host Full Year and Fourth Quarter 2012 Financial Results Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Colo. , Aug. 22, 2014  Cannabis ... in cannabis formulation-based drug development and related consulting, ... iCare,s third international medical cannabis conference taking place ... Strasbourg, France , on October 22, 2014.  ... other stakeholders, such as researchers, health professionals, and ...
(Date:8/22/2014)... - SQI Diagnostics Inc. (TSX-V: SQD), a life ... and products for advanced microarray diagnostics, today announced ... Agreement to contract with a UK-based company to ... initial phase of this agreement, SQI will be ... one of the customer,s assays, operational on SQI,s ...
(Date:8/21/2014)... , Aug. 21, 2014  Aptuit LLC ... West Lafayette, Indiana , has enhanced its ... characterization of small and large molecules, including biologic ... the Bruker maXisPlus Q-TOF mass spectrometer. ... , CEO, Aptuit, said, "The expanded large molecule ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2
... SYDNEY, May 23, 2011 Starpharma Holdings Limited (ASX: ... major phase 2 clinical study that demonstrated efficacy of ... Key Points: VivaGel(R) ... BV VivaGel(R) expected to avoid many shortcomings of ...
... Mass., May 20, 2011 Philips ... Philips FilterLine H Set and VitaLine H Set ... November 2010 through March 2011.ProductProduct DescriptionProduct Lot CodesM1923A ... M8330M10M8386N10M8411P10M8451P10M8477A11M8514A11M8572B11989803159581 , Philips Vitaline H Set Infant/Neo ...
Cached Medicine Technology:VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 2VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 3VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 4VivaGel(R) Demonstrates Efficacy in Bacterial Vaginosis 5Recall of Infant and Neonatal-Sized FilterLine H Set and VitaLine H Set Sampling Lines 2
(Date:8/22/2014)... FL (PRWEB) August 22, 2014 ... treatment facility in Lantana, FL, recently launched a ... just looking for information can now find Millennium ... new website just went live at the beginning ... about the facility can be found on the ...
(Date:8/22/2014)... Beat Eczema , Susan Clark’s ... natural methods to completely cure the eczema symptoms they ... Shane Michaels, prompting an investigative review. , “Although ... it can still be extremely debilitating and life-altering for ... itching and pain that it causes on the skin ...
(Date:8/22/2014)... in advanced non-small cell lung cancer (NSCLC) is ... epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ... deletion independently predicts overall survival (OS) of advanced ... the programmed cell death also known as the ... detected in 12.8% of the Asian population but ...
(Date:8/22/2014)... receptor (EGFR) mutations found in the circulating free tumor ... lung cancer (NSCLC) patients correlates well with the EGFR ... kinase inhibitor (TKI) therapy is approved for EGFR activating ... for determining mutation status is with DNA derived directly ... available. A more abundant and less invasive source of ...
(Date:8/22/2014)... August 22, 2014 Paying tuition and ... in the coming year for four nurse educators pursuing ... National League for Nursing Foundation for Nursing Education . ... share $28,000, $10,000 more than in 2013, thanks to ... Endowment and Elizabeth Isaac Marcil Endowment Funds, both donated ...
Breaking Medicine News(10 mins):Health News:Millennium Treatment Group Has a New Website 2Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:Deletion predicts survival in advanced non-small cell lung cancer 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3
... has been aroused in the identification and isolation of ... of bone marrow cells have been found to have ... on immunological methods is difficult because of the complicated ... of successful passage has been published., A research article ...
... , , WEDNESDAY, April 15 (HealthDay News) -- If you have ... or pop in a CD of mellow songs. , Hospital ... rate and blood pressure just by listening to music, a ... report, published in the latest issue of The Cochrane ...
... Delcath Systems, Inc. (Nasdaq: DCTH ) ... PM Eastern Time on Wednesday, April 22, 2009. Richard ... will host the call.(Logo: http://www.newscom.com/cgi-bin/prnh/20081118/NY46990LOGO ... parties may dial (888) 790-3326 (U.S./Canada) and use Conference ...
... MOUNTAIN VIEW, Calif., April 15 Based on ... tomography (PET) and PET/computed tomography (CT) markets market, ... the 2009 North American Frost & Sullivan Award ... forth innovative scintillation crystal and solid-state photo detector ...
... CITRUS HEIGHTS, Calif., April 15 In response ... (EHR) for all patients, SMART Association, Inc. and ... their LifeMed(TM) Smart Card Platform software for EHRs. ... ("HIEs"), hospital legacy systems, or physicians, record management ...
... need to evaluate options for continuing healthcare coverage , ... ... the 2009 American Recovery and Reinvestment Act (ARRA) may be crucial ... people with disabilities no longer able to work, according to ...
Cached Medicine News:Health News:Soothing Songs Please the Heart 2Health News:Delcath Systems to Host Quarterly Update Conference Call 2Health News:Frost & Sullivan Recognizes Zecotek Photonic's Medical Imaging Achievement, Development of Next-Generation Scintillation Crystals and Photo Detector Technology 2Health News:Frost & Sullivan Recognizes Zecotek Photonic's Medical Imaging Achievement, Development of Next-Generation Scintillation Crystals and Photo Detector Technology 3Health News:Frost & Sullivan Recognizes Zecotek Photonic's Medical Imaging Achievement, Development of Next-Generation Scintillation Crystals and Photo Detector Technology 4Health News:SMART Association, Inc. Launches Its Health Information Exchange Software 2Health News:SMART Association, Inc. Launches Its Health Information Exchange Software 3Health News:Jobless Should Evaluate COBRA, Medicare in Light of 2009 Recovery Act 2Health News:Jobless Should Evaluate COBRA, Medicare in Light of 2009 Recovery Act 3Health News:Jobless Should Evaluate COBRA, Medicare in Light of 2009 Recovery Act 4
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Round handle manufactured in titanium....
Utrata-like fine angled tips with gently curved shaft for performing capsulorhexis through tunnel incisions. Dull finish. Flat handle....
McPherson handle. 45 degree angled shafts. Manufactured in titanium....
This cross action forcep has delicate tips for grasping the capsule. The forcep has an iris stop to prevent inadvertent grasping of the iris....
Medicine Products: